Come by the Turner MedTech to exhibit booth to learn about Turner MedTech's manufacturing capabilities and a chance to meet with Turner MedTech and KyphoLift™ representatives. The company will ...
Analysts are estimating that Lineage Cell Therapeutics will report an earnings per share (EPS) of $-0.04. Anticipation surrounds Lineage Cell Therapeutics's announcement, with investors hoping to hear ...
The Western medical establishment ousted him. China embraced him. Will the man on a mission to perform the first human head transplant ever pull it off?
For the quarter ended September 30, 2024, the Company had a loss from operations of $2.3 million, a 26% year-over-year improvement from $3.1 million for the comparable period of 2023, and a 9% ...
Third Quarter Revenue Growth of 12%Reaffirms Full Year 2024 Revenue Guidance of $116 Million to $120 MillionRepresenting Growth of 27% to 31% BELGRADE, MT / ACCESSWIRE / November 12, 2024 / Xtant ...